Vijaya Diagnostic Centre Ltd.
Snapshot View

View in App

Prices View details >>

460.75 +2.90 ▲0.6%

07 October 2022, 04:01:00 PM
Volume: 14,418

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Hospital & Healthcare Services Compare with Industry peers
Website http://www.vijayadiagnostic.com
Market Cap 4,719.94 Cr.
Enterprise Value(EV) 4,500.15 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 9.23 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 49.94 Trailing Twelve Months Ending 2022-06
Industry PE 50.40 Trailing Twelve Months Ending 2022-06
Book Value / Share 47.42 Trailing Twelve Months Ending 2022-06
Price to Book Value 9.72 Calculated using Price: 460.75
Dividend Yield 0.22 Period Ending 2022-03
No. of Shares Subscribed 10.21 Cr. 102,063,796 Shares
FaceValue 1
Company Profile
The company is one of the fastest-growing diagnostic chains in Southern India. It offers a one-stop solution for pathology and radiology testing services.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.63%
1 Week
+0.03%
1 Month
+5.65%
3 Month
+44.57%
6 Month
+0.55%
1 Year
-19.56%
2 Year
5 Year
10 Year

Ratios View Details >>

4 years 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 22.58 26.07 26.91 26.85
Return on Capital Employed (%) 31.56 35.47 37.97 39.37
Return on Assets (%) 11.42 14.11 16.76 17.85

Balance Sheet View Details >>

Particulars 4 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 207 275 359 468
Non Curr. Liab. 141 148 132 169
Curr. Liab. 57 59 44 66
Minority Int. 0 0 0 1
Equity & Liab. 405 481 535 705
Non Curr. Assets 268 294 296 435
Curr. Assets 137 186 239 270
Misc. Exp. not W/O
Total Assets 405 481 535 705

Profit Loss View Details >>

Particulars 5 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 293 339 377 462 444
Other Income 10 15 12 13 12
Total Income 303 354 389 475 456
Total Expenditure -184 -206 -211 -259 -257
PBIDT 118 148 178 217 199
Interest -14 -15 -15 -16 -17
Depreciation -40 -49 -50 -53 -55
Taxation -19 -21 -27 -37 -32
Exceptional Items
PAT 46 63 85 111 95
Minority Interest -1 -1 -1
Share Associate
Other Related Items
Consolidated Net Profit 46 63 84 110 94
Adjusted EPS 102 138 8 11 9

Cash Flow View Details >>

Particulars 4 years 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 91 106 130 158
Cash Fr. Inv. -90 -31 -130 -123
Cash Fr. Finan. -7 -30 -49 -31
Net Change -7 46 -49 4
Cash & Cash Eqvt 10 56 7 11

Shareholding Pattern View Details >>

4 Qtrs 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 54.78 54.78 54.78 55.04
Public 45.22 45.22 45.22 44.96
Depository Receipts 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00

Announcements View Details >>

Thu, 29 Sep 2022
Shareholder Meeting / Postal Ballot-Outcome of AGM
Pursuant to Regulation 30 of the Securities Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015 we are enclosing herewith the summary of proceedings of the 20th Annual General Meeting of the members of Vijaya Diagnostic Centre Limited held on Wednesday September 28 2022 at 03:00 p.m. (IST) through Video Conferencing (VC) / Other Audio Visual Means (OAVM). We request you to take the same on record.
Thu, 29 Sep 2022
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Pursuant to Regulation 44 (3) of the SEBI (Listing Obligation and Disclosure Requirements) Regulations 2015 we are submitting herewith the details regarding voting results of the business transacted at the 20th Annual General Meeting (AGM) of the Company held on Wednesday September 28 2022 at 03:00 p.m. (IST) through Video Conferencing (VC) / Other Audio Visual Means (OAVM).We are also enclosing the consolidated report of the Scrutinizer dated September 29 2022 on remote e-voting prior and during the AGM.We request you to take the same on record and acknowledge.
Tue, 27 Sep 2022
Closure of Trading Window
This is to inform that as per the Companys Code of Conduct to Regulate Monitor and Report Trading by Designated Persons the Trading Window for dealing in the securities of the Company would remain closed for all designated persons and their immediate relatives with effect from October 1 2022 till end of 48 hours after the declaration of the financial results for the second quarter and half year ending on September 30 2022.Kindly take the same on record.

Technical Scans View Details >>

Thu, 06 Oct 2022
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Closing Above Previous High Closing Above Previous High
Increasing Relative Strength - Sectoral Index Increasing Relative Strength - Sectoral Index

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 228,896.56 953.00 -0.1%
Divi's Laboratories Ltd. 99,171.10 3,738.70 +0.0%
Cipla Ltd. 91,534.16 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. 73,236.99 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. 63,161.01 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. 54,354.34 1,566.00 -2.3%
Zydus Lifesciences Ltd. 42,831.42 421.75 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.85 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 31.94 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-06 36.78 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.49 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.49 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 67.86 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-06 9.69 421.75 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.57 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-06 4.26 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.62 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.63 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.50 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-06 2.55 421.75 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 421.75 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 421.75 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 421.75 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 421.75 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 421.75 -0.3%

FAQ's On Vijaya Diagnostic Centre Ltd.

What is Vijaya Diagnostic share price?
Can I buy Vijaya Diagnostic shares now?
What is the Dividend Yield of Vijaya Diagnostic?
What is the Market Cap of Vijaya Diagnostic?
What are the key metrics to analyse Vijaya Diagnostic?
What is the 52 Week High and Low of Vijaya Diagnostic?
What is the trend of Vijaya Diagnostic share price?